SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Propanc Biopharma Advances Assay Development for Phase 1b Study

Propanc Biopharma said it advanced bioanalytical and immunogenicity assay development for a Phase 1b first-in-human study involving up to 50 advanced cancer patients.

PPCB

Related stories